Next-generation sequencing (NGS) is a powerful tool, and it’s use is growing in basic research and clinical laboratories. Illumina continues to raise the bar on genomic sequencing, democratizing NGS ...
Illumina, Inc. is further extending the reach of the NextSeq 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1 billion reads in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results